Login
Toggle navigation
Videos
Categories
Trending
William Higgons: "We are acquiring Catana, Sii, and Séché Environnement."
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Joël Séché, Président Fondateur de Séché Environnement.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
The Squeeze on Startups: How VC Funding Decline Could Stifle Innovation|Amy Cheetham,Partner,Costanoa Ventures
00:10:00
Enhancing Financial Services with Docupace: A Partnership for Customized Solutions
00:10:00
Head of Human Resources and Director of PT Adaro Energy Indonesia Tbk | EDWIN SOERYADJAYA, CEO, Adaro Energy Indonesia TBK PTPADEF:PKL
00:10:00
Encounter with Cancel Culture in Music Theory|Timothy Jackson,Professor,University of North Texas
00:10:00
Sky Harbor Group Overview: 121 Mining Investment New York 2018
00:10:00
Exploring BBX Minerals' PGM Project and Bioleaching Advances with CEO Andre Duchesne
00:10:00
Toni Townes-Whitley, CEO of Science Applications International Corp. (SAIC), discusses the company's AI investments and fourth-quarter performance.
00:10:00
Neo Lithium's Roadmap: Advancing the 3Q Project in Argentina
00:10:00
Living a Meaningful Life with EP Wealth Advisors' Co-Founder Brian E. Parker | Brian E. Parker, Co-Founder, EP Wealth Advisors.
00:10:00
Partner at Permira Explores AI Trends and Business Impact Beyond Tech | Brian Ruder, Partner, Permira.
00:10:00
Building a AI based company for the Next Generation|Shardul Shah,Founder,Index Ventures
00:10:00
Addressing the Gender Pay Gap in Financial Services with Drs. Tharp, Lurtz, & Mielitz | Daniel Yerger - President of MY Wealth Planners